Supersonic Imagine Aktie [WKN DE: A1KC0V / ISIN: FR0010526814]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Supersonic Imagine SA

01.08.19		Hologic Acquires Approximately 46% of Shares in SuperSonic Imagine, a French Innovator in Ultrasound Medical Imaging (Businesswire)
01.03.18		SuperSonic Imagine Delivers 2,000th Aixplorer® to the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China (Businesswire)
26.02.18		SuperSonic Imagine to Present Aixplorer® Ultimate at the European Congress of Radiology (ECR 2018) (Businesswire)
01.02.18		SuperSonic Imagine: Aixplorer® and Aixplorer® Ultimate Ultrasound Diagnostic Systems Receive 510(k) Clearance for Clinical Management of Liver Disease (Businesswire)
24.01.18		SuperSonic Imagine Announces 2017 Sales Growth of +11% to €24.7 Million (+13% Constant Currency) (Businesswire)
22.12.17		SuperSonic Imagine Announces That It Has Subscribed to the Second Tranche of OBSAs for €6 Million within the Framework of its Venture Loan from Kreos Capital (Businesswire)
11.12.17		SuperSonic Imagine Announces its 2018 Financial Calendar (Businesswire)
07.12.17		SuperSonic Imagine Installs Six Aixplorer® Ultimate Ultrasound Systems at 'Occitanie-Garonne' Medical Imaging Group (Businesswire)
21.11.17		SuperSonic Imagine to Introduce Next-Generation Aixplorer® Ultimate Ultrasound Platform at RSNA 2017 (Businesswire)
19.10.17		SuperSonic Imagine to Showcase Next-Generation Aixplorer® Ultimate’s Solutions for Liver Disease Management at The Liver Meeting 2017 (Businesswire)
18.10.17		SuperSonic Imagine Reports Sales Growth of +13% in Q3 2017 (+16% at Constant Currency) (Businesswire)
11.10.17		SuperSonic Imagine announces the international introduction of Aixplorer® Ultimate at JFR (Businesswire)
31.07.17		New Aixplorer® Ultimate from SuperSonic Imagine (Businesswire)
31.07.17		New Aixplorer® Ultimate from SuperSonic Imagine (Businesswire)
19.07.17		SuperSonic Imagine Announces +16% Sales Growth In Q2 And +16% Over H1 2017 (Businesswire)
20.04.17		SuperSonic Imagine Announces Q1 2017 Revenue Growth of +16% (Businesswire)
24.11.16		SuperSonic Imagine appoints Michèle Lesieur as Chief Executive Officer and President (Businesswire)
22.11.16		SuperSonic Imagine to Present Newly Upgraded Aixplorer® Ultrasound Platform at RSNA 2016 (Businesswire)
21.11.16		SuperSonic Imagine Receives FDA 510(k) Clearance for its New Innovative Breast and Liver Package on Aixplorer (Businesswire)
10.11.16		SuperSonic Imagine to Feature its Non-Invasive, 60-Second Liver Exam at The Liver Meeting 2016 (Businesswire)
02.11.16		SuperSonic Imagine Announces Appointment of Michael Brock as Supervisory Board Chairman (Businesswire)
18.10.16		SuperSonic Imagine Reports Sales Growth of +10% in Q3 2016 (Businesswire)
13.10.16		SuperSonic Imagine to Present Newly Upgraded Aixplorer® Ultrasound Platform at JFR in Paris (Businesswire)
15.09.16		SuperSonic Imagine Releases Major Upgrade to the Innovative Aixplorer® Ultrasound Platform (Businesswire)
19.07.16		SuperSonic Imagine: H1 2016 Sales: +7% to €8.9m (Businesswire)
23.06.16		SuperSonic Imagine Announces the Completion of Patient Enrollment for Pivotal Liver Fibrosis Clinical Study in China (Businesswire)
26.05.16		Supersonic Imagine Receives Regulatory Approval in Japan for New Advancements on the Aixplorer® Ultrasound System (Businesswire)
12.05.16		SuperSonic Imagine’s Advanced Ultrasound Technology Adopted by Sports Medicine Professionals (Businesswire)
19.04.16		SuperSonic Imagine: 1Q 2016 revenue growth: +21% to €3.9m (Businesswire)
13.04.16		SuperSonic Imagine to Demonstrate its Non-Invasive, 60-Second Liver Assessment Exam at the International Liver Congress™ (ILC 2016) Barcelona, Spain (Businesswire)
07.04.16		SuperSonic Imagine Showcases Breast Imaging Innovations at Key Conferences (Businesswire)
14.03.16		SuperSonic Imagine Announces its 2015 Results and Enters Into a Commercial Partnership with Sandhill Scientific in the USA to Take Advantage of the Rapidly Growing Liver Market (Businesswire)
01.03.16		SuperSonic Imagine Showcases Clinical Innovations During the European Congress of Radiology (Businesswire)
25.01.16		SuperSonic Imagine Highlights the Clinical Benefits of Real-Time ShearWave Elastography in the Middle East (Businesswire)
19.01.16		SuperSonic Imagine: 2015 Annual Sales: +2% to €20.1 Million (Businesswire)
06.01.16		SuperSonic Imagine Announces Its 2016 Financial Calendar (Businesswire)
14.12.15		SuperSonic Imagine Appoints Bernard Doorenbos as Interim President and Chief Executive Officer (Businesswire)
23.11.15		SuperSonic Imagine to Highlight Advancement in Microvascular Imaging at Annual Radiology Meeting (Businesswire)
12.11.15		SuperSonic Imagine to Showcase Its Non-Invasive, 60-Second Liver Assessment Exam as an Alternative to Biopsy (Businesswire)
10.11.15		SuperSonic Imagine Announces Completion of Key Milestone in Largest ShearWaveTM Elastography Breast Cancer Study (Businesswire)
20.10.15		SuperSonic Imagine: Solid Q3 Product Sales Growth: +21% (Businesswire)
15.10.15		SuperSonic Imagine To Demonstrate Breakthrough Ultrasensitive Technology for Microvascular Imaging for the First Time at the French Radiology Congress (Businesswire)
13.10.15		SuperSonic Imagine Announces the Recognition of ShearWave™ Elastography’s Exceptional Clinical Value in Mettler Institute’s Award Winning Presentation (Businesswire)
01.10.15		SuperSonic Imagine Appoints Dr. Hermann Requardt as Supervisory Board Chairman (Businesswire)
14.09.15		SuperSonic Imagine Reports 2015 First-Half Results (Businesswire)
09.09.15		SuperSonic Imagine Introduces Single Crystal Curved XC6-1 Probe for the Aixplorer® Ultrasound System (Businesswire)
21.07.15		SuperSonic Imagine : 1H 2015 Sales: + 2% to €8.3 million (Businesswire)
23.06.15		SuperSonic Imagine Appoints Philippe Lutman as Executive Vice President and Chief Customer Fulfilment Officer (Businesswire)
29.05.15		SuperSonic Imagine Announces the Appointment of Bernard Doorenbos as President of Supervisory Board (Businesswire)
28.05.15		SuperSonic Imagine Announces Regulatory Clearance of the Next-Generation Aixplorer® Ultrasound System in Japan (Businesswire)

1 | Weiter

Newssuche

Meistgelesene Nachrichten

Drohende Korrektur? Experte schlägt Alarm bei der NVIDIA-Aktie

Flugzeugabsturz nahe Vilnius: DHL-Auftragnehmer in schweren Unfall verwickelt - DHL-Aktie etwas schwächer

Italiens UniCredit will Banco BPM schlucken - Scheitert jetzt die Commerzbank-Übernahme? - Aktien unter Druck

Pierer Mobility-Aktie zieht zweistellig an: Pierer Industrie AG hat Restrukturierungsverfahren eingeleitet

Bitcoin im Fokus: MicroStrategy sorgt für Spannung mit potenziellen Käufen

Erstes Alarmsignal seit 2008: Droht dem Aktienmarkt eine Krise?

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	28.11.2024 02:27
Kaufwert:	EUR
	Hinzufügen Speichern